Loading...
Circulating tumor cell enumeration in a phase II trial of a four-drug regimen in advanced colorectal cancer.
Krebs, Matthew G Renehan, Andrew G Backen, Alison C Gollins, S Chau, I Hasan, Jurjees Valle, Juan W Morris, Karen Beech, Janette Ashcroft, Linda
Krebs, Matthew G
Renehan, Andrew G
Backen, Alison C
Gollins, S
Chau, I
Hasan, Jurjees
Valle, Juan W
Morris, Karen
Beech, Janette
Ashcroft, Linda
Citations
Altmetric:
Abstract
Multidrug regimens are active against advanced colorectal cancer (ACRC). However, the increased toxicity requires the use of biomarkers to select the patients who will derive the most benefit. We assessed circulating tumor cells (CTCs) as a prognostic biomarker in patients treated with a 4-drug regimen.
Description
Date
2014-12-31
Publisher
Collections
Keywords
Type
Article
Citation
Circulating tumor cell enumeration in a phase II trial of a four-drug regimen in advanced colorectal cancer: Clin Colorectal Cancer